NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-014-2007-0-SG-16 SMOOTHENED POLYPEPTIDES AND METHODS OF USE SG National Stage 200903030-5 Abandoned
NCI E-014-2007-0-ID-08 SMOOTHENED POLYPEPTIDES AND METHODS OF USE ID National Stage W-00200901121 Abandoned
NCI E-014-2007-0-KR-11 SMOOTHENED POLYPEPTIDES AND METHODS OF USE KR National Stage 10-2009-7008873 Abandoned
NCI E-152-2007-0-US-11 Non-M Non-O HiV Strains, Fragments And Uses US DIV 12/385,973 8227185 Expired PDF
NCI E-304-2006-0-US-03 Modified T Cell Receptors and Related Materials and Methods. US National Stage 12/443,111 8088379 Issued PDF
NCI E-014-2007-0-PH-15 SMOOTHENED POLYPEPTIDES AND METHODS OF USE PH National Stage 1-2009-500816 Abandoned
NCI E-014-2007-0-JP-10 SMOOTHENED POLYPEPTIDES AND METHODS OF USE JP National Stage 2009-534941 Abandoned
NCI E-324-2001-2-US-03 Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with Neuroblastoma US National Stage 11/572,667 8283122 Abandoned PDF
NCI E-014-2007-0-ZA-18 SMOOTHENED POLYPEPTIDES AND METHODS OF USE ZA National Stage 2009/02894 Abandoned
NCI E-116-2003-0-US-04 Immunogenic Peptides And Peptide Derivatives For Prostate And Breast Cancer Treatment US DIV 12/430,837 8043623 Issued PDF
CC E-066-2010-0-US-04 SYSTEM AND METHOD FOR FUSING REAL-TIME ULTRASOUND IMAGES WITH PRE-ACQUIRED MEDICAL IMAGES US National Stage 12/516,407 8731264 Issued PDF
NCI E-050-2007-2-ES-09 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) ES EP 07867402.5 Abandoned
NCI E-050-2007-2-DE-08 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) DE EP 07867402.5 Abandoned
NHLBI E-160-2002-0-US-08 Trypotophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins US CON 12/430,023 7923535 Expired PDF
NIMH E-157-2006-1-JP-05 Methods To Identify Patients At Risk Of Developing Adverse Events During Treatment With Antidepressant Medication JP National Stage 534893/2009 Abandoned
NHLBI E-337-2008-0-US-01 Self-expanding Stent For Aortic Valve Replacement US 61/172,568 Abandoned
NIAMS E-116-2005-0-US-03 Tissue Engineered Cartilage, Methods o Making Same, Theuraputics and Cosmetic Surgical Application Using Same US National Stage 11/922,251 8202551 Abandoned PDF
NCI E-140-2006-0-US-02 A Fullerene-based Anticoagulent US National Stage 12/446,967 Abandoned
NCI E-097-2009-0-US-01 Chimeric Mouse/human Anti-human ROR1 MAb 2A2 US 61/172,099 Abandoned
NICHD E-145-2009-0-US-01 Pyro-glutamate Serpinin (pE-Serpinin), A Novel Protection Peptide Against Oxidative Stress In Cell And A Biomarker For Inflammatory Disease US 61/172,013 Abandoned
NHGRI E-053-2009-0-US-01 Methods for Diagnosis and Prognosis of Melanoma by Detection of Somatic Mutations in the MITF Pathway US 61/214,415 Abandoned
NINDS E-081-2008-2-FR-09 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems FR EP 09731740.8 Issued
NINDS E-081-2008-2-DE-08 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems DE EP 09731740.8 Issued
NINDS E-081-2008-2-GB-10 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems GB EP 09731740.8 Issued
NINDS E-081-2008-2-EP-04 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems EP National Stage 09731740.8 Issued
NINDS E-081-2008-2-CA-03 Magnetic Microstructures For Magnetic Resonance Imaging CA National Stage 2721797 Issued
NINDS E-081-2008-2-AU-02 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems AU National Stage 2009237570 Issued
NIAID E-285-2002-0-FR-23 Lutzomyia Longipalpis Polypeptides and Methods of Use FR EP 09158294.0 Expired
NIAID E-285-2002-0-EP-14 Lutzomyia Longipalpis Polypeptides and Methods of Use EP DIV 09158294.0 Expired
NIAID E-285-2002-0-IT-24 Lutzomyia Longipalpis Polypeptides and Methods of Use IT EP 09158294.0 Expired
NIAID E-285-2002-0-ES-22 Lutzomyia Longipalpis Polypeptides and Methods of Use ES EP 09158294.0 Expired
NCI E-308-2000-0-US-10 Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same US DIV 12/426,901 Abandoned
NICHD E-133-1990-0-US-05 GOSSYPOL FOR THE TREATMENT OF CANCER US CON 12/426,841 Abandoned
NINDS E-081-2008-2-PCT-01 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems PCT PCT COMB PCT/US09/041142 Expired
NCI E-042-2009-0-US-01 A Human Cytolytic T Lymphocyte Epilope From The Human Tumor-associated Antigen NGEP (new Gene Expressed In Prostate) US 61/170,900 Abandoned
NINDS E-144-2008-0-PCT-02 MRI Movement Correction PCT PCT PCT/US09/40948 Expired
NCI E-049-2008-0-PCT-02 Cripto-l As A Biomarker for Cardiac Hypoxia PCT PCT PCT/US09/40971 Abandoned
NINDS E-144-2008-0-EP-03 MRI Movement Correction in MRI Using A Camera EP National Stage 09731954.5 Abandoned
NCI E-075-2008-0-PCT-02 Cripto-1 As A Biomarker for Chronic Inflammatory Disease PCT PCT PCT/US09/40980 Abandoned
NCI E-184-2009-0-US-01 Combination Immunotherapy Compositions And Methods US 61/170,530 Abandoned
NIAAA E-061-2010-0-EP-02 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE EP National Stage 09789597.3 Issued
NIAAA E-060-2010-0-IN-04 Hydroxybutyrate Ester And Medical Use Thereof IN National Stage 544/MUMNP/2011 Issued
NIAAA E-060-2010-0-CA-07 Hydroxybutyrate Ester And Medical Use Thereof CA National Stage 2734720 Issued
NIAAA E-061-2010-0-AU-06 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE AU National Stage 2009344282 Issued
NIAAA E-060-2010-0-AU-03 Hydroxybutyrate Ester And Medical Use Thereof AU National Stage 2009283171 Issued
NIAAA E-060-2010-0-CN-05 Hydroxybutyrate Ester And Medical Use Thereof CN National Stage 200980136723.1 Pending
NIAAA E-061-2010-0-IN-05 inPROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE IN National Stage 2333/MUMNP/2011 Pending
NIAAA E-060-2010-0-EP-08 Hydroxybutyrate Ester And Medical Use Thereof EP National Stage 09789596.5 Pending
NIAAA E-060-2010-0-JP-09 Hydroxybutyrate Ester And Medical Use Thereof JP National Stage 2011-523833 Pending
NIAAA E-061-2010-0-CA-04 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE CA National Stage 2760410 Abandoned